Pentazocine and zolpidem addiction in a sickle cell anemia patient
Saved in:
Main Authors: | Mandakini Bhowmick, Suprakash Chaudhury |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
Series: | Industrial Psychiatry Journal |
Online Access: | https://journals.lww.com/10.4103/ipj.ipj_33_23 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pentazocine Misuse among Sickle Cell Disease Patients and The Role of Lack of Enforcement of Opioid Dispensing Regulations by Community Pharmacies: A Descriptive Observational Study
by: Oluomachi Charity Nnachi, et al.
Published: (2022-01-01) -
The endocannabinoid system’s genetic polymorphisms in sickle cell anemia patients
by: Amanda Cristina Meneguetti Berti, et al.
Published: (2024-12-01) -
Safety of Pegfilgrastim (Neulasta) in Patients with Sickle Cell Trait/Anemia
by: Pashtoon Murtaza Kasi, et al.
Published: (2013-01-01) -
Sickling Cells, Cyclic Nucleotides, and Protein Kinases: The Pathophysiology of Urogenital Disorders in Sickle Cell Anemia
by: Mário Angelo Claudino, et al.
Published: (2012-01-01) -
Outcome of pregnancy in sickle cell anemia patients with COVID-19 infection
by: Vaidyanathan Gowri, et al.
Published: (2024-01-01)